Log In
BCIQ
Print this Print this
 

MNRP1685 (R7347) (formerly Anti-NRP1, RG7347)

  Manage Alerts
Collapse Summary General Information
Company Genentech Inc.
DescriptionRecombinant human mAb that binds to Neuropilin-1 (NRP1)
Molecular Target Neuropilin 1 (NRP1)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
PartnerRoche

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today